BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20595932)

  • 1. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation.
    Reich-Zeliger S; Eidelstein Y; Hagin D; Antebi YE; Seger R; Reisner Y
    Transplantation; 2010 Aug; 90(4):380-6. PubMed ID: 20595932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
    Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
    J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
    Rich RF; Cook WJ; Green WR
    Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
    Hiruma K; Gress RE
    J Immunol; 1992 Sep; 149(5):1539-47. PubMed ID: 1387142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions.
    Rich RF; Green WR
    Viral Immunol; 2006; 19(3):424-33. PubMed ID: 16987061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway.
    Li LB; Goleva E; Hall CF; Ou LS; Leung DY
    J Allergy Clin Immunol; 2004 Nov; 114(5):1059-69. PubMed ID: 15536411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
    Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
    J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossing the HLA barriers.
    Reisner Y; Gur H; Reich-Zeliger S; Martelli MF; Bachar-Lustig E
    Blood Cells Mol Dis; 2004; 33(3):206-10. PubMed ID: 15528132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veto activity of activated bone marrow does not require perforin and Fas ligand.
    Chrobak P; Gress RE
    Cell Immunol; 2001 Mar; 208(2):80-7. PubMed ID: 11333140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells.
    Reich-Zeliger S; Bachar-Lustig E; Bar-Ilan A; Reisner Y
    J Immunol; 2007 Nov; 179(10):6389-94. PubMed ID: 17982025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2-dependent pathways are essential for CD8+ T cell-mediated airway hyperresponsiveness and inflammation.
    Ohnishi H; Takeda K; Domenico J; Lucas JJ; Miyahara N; Swasey CH; Dakhama A; Gelfand EW
    J Allergy Clin Immunol; 2009 Jan; 123(1):249-57. PubMed ID: 19130938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.